World's Best Scientists 2026 revealed!
Award Badge
Immunology
USA
2026

D-Index & Metrics

Immunology

D-Index
152
Citations
95951
World Ranking
113
National Ranking
72

Medicine

D-Index
152
Citations
95965
World Ranking
1069
National Ranking
615

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Immunology in United States Leader Award

Overview

Barney S. Graham is affiliated with Morehouse School of Medicine in the United States. Their research is primarily situated within the field of Medicine, with significant contributions to specialized subfields including Infectious Diseases, Epidemiology, Animal Science and Zoology, Immunology, and Molecular Biology.

The main research topics explored include SARS-CoV-2 and COVID-19 Research, Animal Virus Infections Studies, Respiratory Viral Infections Research, Viral Gastroenteritis Research and Epidemiology, Influenza Virus Research Studies, Immunotherapy and Immune Responses, and COVID-19 Clinical Research Studies.

Barney S. Graham has coauthored work frequently with the following researchers:

  • John R. Mascola
  • Kizzmekia S. Corbett
  • Masaru Kanekiyo
  • Lingshu Wang
  • Adrian B. McDermott

Several notable papers published by Barney S. Graham include:

  • Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation (2020, Science)
  • An mRNA Vaccine against SARS-CoV-2 - Preliminary Report (2020, New England Journal of Medicine)
  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020, New England Journal of Medicine)
  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness (2020, Nature)
  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020, New England Journal of Medicine)

Barney S. Graham's publications have appeared most frequently in the following venues:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • New England Journal of Medicine
  • Science Translational Medicine
  • UNC Libraries
  • Science

Best Publications

  • Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.

    Daniel Wrapp;Nianshuang Wang;Kizzmekia S. Corbett;Jory A. Goldsmith

  • Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

    Lindsey R. Baden;Hana M El Sahly;Brandon J Essink;Karen Kotloff

  • An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

    Lisa A. Jackson;Evan J. Anderson;Nadine G. Rouphael;Paul C. Roberts

  • Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

    Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani

  • SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.

    Kizzmekia S. Corbett;Darin K. Edwards;Sarah R. Leist;Olubukola M. Abiona

  • Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.

    Evan J. Anderson;Nadine G. Rouphael;Alicia T. Widge;Lisa A. Jackson

  • Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

    Jesper Pallesen;Nianshuang Wang;Kizzmekia S. Corbett;Daniel Wrapp

  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

    Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

    Jason S. McLellan;Man Chen;Sherman Leung;Kevin W. Graepel

  • Protection Against Malaria by Intravenous Immunization with a Nonreplicating Sporozoite Vaccine

    Robert A. Seder;Lee Jah Chang;Mary E. Enama;Kathryn L. Zephir

  • Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo.

    Anne W. Rimoin;Prime M. Mulembakani;Sara C. Johnston;James O. Lloyd Smith

  • Rapid COVID-19 vaccine development.

    Barney S. Graham

  • Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination

    Norbert Pardi;Michael J. Hogan;Rebecca S. Pelc;Hiromi Muramatsu

  • Animal models for COVID-19.

    César Muñoz-Fontela;William E. Dowling;Simon G.P. Funnell;Pierre S. Gsell

  • Pre-fusion structure of a human coronavirus spike protein

    Robert N. Kirchdoerfer;Christopher A. Cottrell;Nianshuang Wang;Jesper Pallesen

  • Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination.

    Alicia T. Widge;Nadine G. Rouphael;Lisa A. Jackson;Evan J. Anderson

  • Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection

    Hadi M. Yassine;Jeffrey C. Boyington;Patrick M. McTamney;Patrick M. McTamney;Chih Jen Wei;Chih Jen Wei

  • Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

    Scott M. Hammer;Magdalena E. Sobieszczyk;Holly Janes;Shelly T. Karuna

  • Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19.

    Nicole Doria-Rose;Mehul S. Suthar;Mat Makowski;Sarah O’Connell

  • Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

    Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Julie E. Ledgerwood
Julie E. Ledgerwood National Institute of Allergy and Infectious Diseases
Richard A. Koup
Richard A. Koup National Institute of Allergy and Infectious Diseases
Robert T. Bailer
Robert T. Bailer National Institute of Allergy and Infectious Diseases
Jason S. McLellan
Jason S. McLellan The University of Texas at Austin
Gary J. Nabel
Gary J. Nabel ModeX Therapeutics
Michael C. Keefer
Michael C. Keefer University of Rochester
Mario Roederer
Mario Roederer National Institute of Allergy and Infectious Diseases
M. Juliana McElrath
M. Juliana McElrath University of Washington
Kizzmekia S. Corbett
Kizzmekia S. Corbett Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring complementary healthcare degrees can broaden career opportunities. Many students transition into advanced nursing roles, such as Acute Care Nurse Practitioners, by enrolling in specialized acute care nurse practitioner programs. These programs prepare nurses to manage complex patient cases often linked with immunological disorders.

Accelerated pathways like accelerated RN to NP programs offer a fast track for registered nurses seeking to advance in their careers. These flexible online options allow students to gain clinical expertise and nursing leadership skills applicable in immunology-related healthcare settings.

For those starting without a nursing background, 12-month accelerated nursing programs online for non nurses provide an efficient route to enter the field. These programs quickly equip learners with foundational nursing knowledge needed to engage in specialized areas like immunology.

Finding accessible education is important, and many prospective students search for accelerated nursing programs near me. Local options combined with online flexibility make pursuing nursing alongside immunology both practical and achievable.

Best Scientists Citing Barney S. Graham

Trending Scientists

Recently Published Articles